相似文献
1
Interleukin-22: immunobiology and pathology.
Annu Rev Immunol. 2015;33:747-85. doi: 10.1146/annurev-immunol-032414-112123. Epub 2015 Feb 11.
2
MicroRNAs: New regulators of IL-22.
Cell Immunol. 2016 Jun-Jul;304-305:1-8. doi: 10.1016/j.cellimm.2016.05.003. Epub 2016 May 17.
3
Distribution of Interleukin-22-secreting Immune Cells in Conjunctival Associated Lymphoid Tissue.
Korean J Ophthalmol. 2018 Apr;32(2):147-153. doi: 10.3341/kjo.2017.0068. Epub 2018 Mar 19.
4
A comprehensive review of IL-26 to pave a new way for a profound understanding of the pathobiology of cancer, inflammatory diseases and infections.
Immunology. 2022 Jan;165(1):44-60. doi: 10.1111/imm.13424. Epub 2021 Nov 8.
5
Functional biology of the IL-22-IL-22R pathway in regulating immunity and inflammation at barrier surfaces.
Adv Immunol. 2010;107:1-29. doi: 10.1016/B978-0-12-381300-8.00001-0.
6
IL-22, not simply a Th17 cytokine.
Immunol Rev. 2013 Mar;252(1):116-32. doi: 10.1111/imr.12027.
7
Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: in situ analysis using a novel Il-33-LacZ gene trap reporter strain.
J Immunol. 2012 Apr 1;188(7):3488-95. doi: 10.4049/jimmunol.1101977. Epub 2012 Feb 27.
8
Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells.
Cytokine Growth Factor Rev. 2006 Oct;17(5):367-80. doi: 10.1016/j.cytogfr.2006.09.001. Epub 2006 Oct 9.
9
Interleukin-22: a potential therapeutic target in atherosclerosis.
Mol Med. 2021 Aug 13;27(1):88. doi: 10.1186/s10020-021-00353-9.
10
Heterogeneity and diversity of group 3 innate lymphoid cells: new cells on the block.
Int Immunol. 2016 Jan;28(1):29-34. doi: 10.1093/intimm/dxv054. Epub 2015 Oct 13.
引用本文的文献
1
sp. nov., a novel pathogenic species isolated from tuberculous pleurisy patient.
Front Cell Infect Microbiol. 2025 Aug 7;15:1629703. doi: 10.3389/fcimb.2025.1629703. eCollection 2025.
2
CRISPRi Screening Identifies SON and MAP4K1 as Regulators of Type III Cytokine Expression in Innate Lymphoid Cells.
bioRxiv. 2025 Aug 15:2025.08.15.670561. doi: 10.1101/2025.08.15.670561.
3
HPV16 E6 and E7 expressing cancer cells suppress the antitumor immune response by upregulating KLF2-mediated IL-23 expression in macrophages.
J Immunother Cancer. 2025 Aug 19;13(8):e011915. doi: 10.1136/jitc-2025-011915.
4
IL-20 Subfamily Biological Effects: Mechanistic Insights and Therapeutic Perspectives in Cancer.
Int J Mol Sci. 2025 Jul 29;26(15):7320. doi: 10.3390/ijms26157320.
5
The Intriguing Roles of Cytokines in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review.
Curr Obes Rep. 2025 Aug 12;14(1):65. doi: 10.1007/s13679-025-00657-5.
6
Evaluating IL22RA1 expression as a predictive indicator in human colon cancer progression.
BMC Cancer. 2025 Aug 7;25(1):1278. doi: 10.1186/s12885-025-14715-7.
7
T17 cells regulate chemokine expression in epithelial cells through C/EBPβ and dictate host sensitivity to colitis and cancer immunity.
Sci Adv. 2025 Aug;11(31):eads3530. doi: 10.1126/sciadv.ads3530. Epub 2025 Aug 1.
8
Serum Levels of IL-21 and IL-22 in Breast Cancer Patients-A Preliminary Study.
Curr Issues Mol Biol. 2025 Jul 10;47(7):537. doi: 10.3390/cimb47070537.
9
Burning Down the House: Thymic Repair and Regeneration After Acute Damage.
Immunol Rev. 2025 Jul;332(1):e70050. doi: 10.1111/imr.70050.
10
Inflammation in Asthma: Mechanistic Insights and the Role of Biologics in Therapeutic Frontiers.
Biomedicines. 2025 May 30;13(6):1342. doi: 10.3390/biomedicines13061342.
本文引用的文献
1
The involvement of interleukin-22 in the expression of pancreatic beta cell regenerative Reg genes.
Cell Regen. 2013 Apr 4;2(1):2. doi: 10.1186/2045-9769-2-2. eCollection 2013.
2
Nfil3 is crucial for development of innate lymphoid cells and host protection against intestinal pathogens.
J Exp Med. 2014 Aug 25;211(9):1723-31. doi: 10.1084/jem.20140212. Epub 2014 Aug 11.
3
Nfil3 is required for the development of all innate lymphoid cell subsets.
J Exp Med. 2014 Aug 25;211(9):1733-40. doi: 10.1084/jem.20140145. Epub 2014 Aug 4.
4
CX₃CR1⁺ mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22.
J Exp Med. 2014 Jul 28;211(8):1571-83. doi: 10.1084/jem.20140678. Epub 2014 Jul 14.
5
Inhibition of keratinocyte differentiation by the synergistic effect of IL-17A, IL-22, IL-1α, TNFα and oncostatin M.
PLoS One. 2014 Jul 10;9(7):e101937. doi: 10.1371/journal.pone.0101937. eCollection 2014.
6
Cross-talk between RORγt+ innate lymphoid cells and intestinal macrophages induces mucosal IL-22 production in Crohn's disease.
Inflamm Bowel Dis. 2014 Aug;20(8):1426-34. doi: 10.1097/MIB.0000000000000105.
7
In vivo analysis of helper T cell responses in patients with autoimmune polyendocrinopathy - candidiasis - ectodermal dystrophy provides evidence in support of an IL-22 defect.
Autoimmunity. 2014 Dec;47(8):556-62. doi: 10.3109/08916934.2014.929666. Epub 2014 Jun 24.
8
Genetic polymorphisms and plasma levels of interleukin-22 contribute to the development of nonsmall cell lung cancer.
DNA Cell Biol. 2014 Oct;33(10):705-14. doi: 10.1089/dna.2014.2432. Epub 2014 Jun 23.
9
The transcription Factor AHR prevents the differentiation of a stage 3 innate lymphoid cell subset to natural killer cells.
Cell Rep. 2014 Jul 10;8(1):150-62. doi: 10.1016/j.celrep.2014.05.042. Epub 2014 Jun 19.
10
Directing traffic: IL-17 and IL-22 coordinate pulmonary immune defense.
Immunol Rev. 2014 Jul;260(1):129-44. doi: 10.1111/imr.12183.
Zotero 插件